Northway Biotech
Vladas Algirdas Bumelis has a rich and diverse work experience in the biopharmaceutical industry. Vladas Algirdas is currently the CEO and Chairman of the Board at Northway Biotech, a Contract Development and Manufacturing Organization (CDMO) specializing in biopharmaceuticals. In this role, they oversee the company's R&D and GMP manufacturing facilities, ensuring the successful development and production of pharmaceutical molecules. Prior to their current position, Bumelis held various leadership roles at Biotechpharma, another CDMO in the industry. Vladas Algirdas also served as the Head and Chief Researcher at the Biopharmaceutical Division of the Center for Innovative Medicine. Bumelis has extensive experience in academia as well, having been a Professor at Vilnius Gediminas Technical University and Vilnius University. Vladas Algirdas has also worked as a consultant at LTD "Teva Pharmaceuticals". Earlier in their career, Bumelis held executive positions at UAB "Sicor Biotech" / Teva Baltic, BIOFA AB, BIOTECHNOLOGY INSTITUTE "FERMENTAS," and SCIENCE/PRODUCTION ASSOCIATION "FERMENTAS." Vladas Algirdas started their professional journey as a Senior Research Fellow at the UNION INSTITUTE FOR APPLIED ENZYMOLOGY. Overall, Bumelis has a deep understanding of the biopharmaceutical industry and has made significant contributions to research, development, manufacturing, and academia throughout their career.
Vladas Algirdas Bumelis has a strong education background. Vladas Algirdas obtained a Diploma of higher education from Vilnius University in 1971, majoring in Chemistry. In 1975, they completed their Ph.D. in Chemistry at Vilnius University as well. Vladas Algirdas then went on to earn the pedagogic title of the Senior Researcher in 1986, also from Vilnius University. Additionally, in 1993, they received a Habil. Doctoral dissertation on "Interferons and their properties" from Vilnius University's Union Institute for Research and Design in Applied Biochemistry. Furthermore, they acquired the pedagogic title of the Docent from Vilnius University in 1994. Lastly, in 1995, they were awarded the pedagogic title of the Professor from Vytautas Magnus University.
This person is not in any offices
Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) located in Waltham, MA, USA, and Vilnius, Lithuania, EU. Extensive expertise in drug substance and drug product development, as well as GMP compliant manufacturing, makes us exceptionally well-versed in all aspects of the biopharmaceutical value chain – from gene to drug manufacturing in microbial and mammalian expressions systems. Our customers appreciate our ability to react rapidly to unexpected project changes, adjusting timelines, and availability of additional capabilities to meet our customers' evolving needs. We are deeply invested in providing high-quality, world-class contract development and manufacturing services with vast flexibility and responsiveness backed by a strong foundation in science and technology innovation. Northway Biotech end-to-end services include: Cell Line (Mammalian & Microbial) Development Analytical Methods Development Formulation Development Upstream & Downstream Process Development (USP & DSP) cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product) cGMP Master and Working Cell Bank Manufacturing cGMP pDNA Manufacturing Fill & Finish (F&F) Quality Assurance, Quality Control, and Regulatory CMC Support